Diversity of greek meningococcal serogroup B isolates and estimated coverage of the 4CMenB meningococcal vaccine

BACKGROUND: Serogroup B meningococcal (MenB) isolates currently account for approximately 90% of invasive meningococcal disease (IMD) in Greece with ST-162 clonal complex predominating. The potential of a multicomponent meningococcal B vaccine (4CMenB) recently licensed in Europe was investigated in...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Tzanakaki, Georgina, Hong, Eva, Kesanopoulos, Konstatinos, Xirogianni, Athanasia, Bambini, Stefania, Orlandi, Luca, Comanducci, Maurizio, Muzzi, Alessandro, Taha, Muhamed-Kheir
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: BioMed Central 2014
Konular:
Research Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC4018652/
https://ncbi.nlm.nih.gov/pubmed/24779381
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2180-14-111
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller